title: Brain Fos expression during 48 h after cisplatin treatment: neural pathways for acute and delayed visceral sickness.
abstract: Cancer chemotherapy drugs, such as cisplatin, are extremely potent for producing nausea and vomiting. The acute effects of these treatments are partly controlled using anti-emetic drugs, but the delayed effects (>24 h), especially nausea, are much more difficult to treat. Furthermore, cisplatin induces a long-term (up to 48 h) increase in pica in rats. Pica is manifested as an increase in consumption of kaolin (clay) and is used as a measure of visceral sickness. It is unknown what brain pathways might be responsible for this sickness associated behavior. As a first attempt to define this neural system, rats were injected (i.p.) with 3, 6, or 10 mg/kg cisplatin (doses reported to produce pica) and sacrificed at 6, 24, or 48 h to determine brain Fos expression. The primary results indicate: 1) increasing the dose of cisplatin increased the magnitude and duration of brain Fos expression, 2) most excitatory effects on hindbrain nucleus of the solitary tract (NTS) and area postrema (AP) Fos expression occurred within 24 h after cisplatin injection, 3) 6 and 10 mg/kg cisplatin treatment produced large increases in Fos expression in the central amygdala (CeA) and bed nucleus of the stria terminalis (BNST), including 48 h after injection, and 4) cisplatin treatment produced little effect on Fos expression in the paraventricular and supraoptic nuclei of the hypothalamus. These results indicate that cisplatin activates a neural system that includes the dorsal vagal complex (NTS and AP), CeA, and BNST.
authors.affiliation: Monell Chemical Senses Center, 3500 Market Street, Philadephia, PA 19104, USA. Horn@monell.org
authors.forename: Charles C
authors.initials: CC
authors.lastname: Horn
authors.forename: Marc
authors.initials: M
authors.lastname: Ciucci
authors.forename: Arun
authors.initials: A
authors.lastname: Chaudhury
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D002945:Cisplatin / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D007150:Immunohistochemistry; D008297:Male; D009325:Nausea / Q000209:etiology*; D009434:Neural Pathways / Q000187:drug effects / Q000378:metabolism; D010842:Pica / Q000209:etiology; D016760:Proto-Oncogene Proteins c-fos / Q000096:biosynthesis* / Q000187:drug effects; D051381:Rats; D017207:Rats, Sprague-Dawley; D014839:Vomiting / Q000209:etiology*
chemical_list: D000970:Antineoplastic Agents; D016760:Proto-Oncogene Proteins c-fos; D002945:Cisplatin